| 摘要 |
PROBLEM TO BE SOLVED: To provide novel treatment of pediatric acute lymphoblastic leukemia.SOLUTION: There is provided a pharmaceutical composition comprising a CD19xCD3 bispecific single chain antibody construct for the treatment, amelioration or elimination of pediatric acute lymphoblastic leukemia (ALL) in a pediatric ALL patient. |
